{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": "Invests in derivatives and structured products such as CLOs",
    "classification": "complex",
    "supporting_data": "Although UCITS ETFs are generally presumed non-complex under MiFID II due to their regulated nature and investor protections, this presumption is overturned if the ETF invests in derivatives or structured products that embed derivatives or have complex payoff structures. The LS ARK Innovation Tracker ETP is a collateralised exchange traded security linked to a reference asset and involves derivative exposure. According to MiFID II Article 25(4)(a)(iv) and the Commission Delegated Regulation Article 57, UCITS ETFs that invest significantly in derivatives or structured products like CLOs are considered structured UCITS and are excluded from the automatic non-complex classification. Such ETFs fail the Article 57 criteria, particularly the exclusion of instruments embedding derivatives (Article 57(a)) and the requirement for transparent, easily understandable information (Article 57(f)). The presence of derivatives integral to the investment strategy introduces counterparty and collateral risks that are difficult for retail investors to understand, making the product complex. ESMA and CESR guidance confirm that synthetic or structured UCITS ETFs should be classified as complex and require an appropriateness assessment. Therefore, despite being UCITS, the ETF's use of derivatives and structured products like CLOs leads to a complex classification under MiFID II. This classification requires firms to assess the retail investor's knowledge and experience before sale to ensure understanding of risks such as counterparty risk, leverage, and illiquidity. No significant leverage beyond UCITS limits is indicated, and replication is physical, but the derivative and structured product exposure drives complexity. The product's high risk rating (6/7) reflects market risk but combined with derivative exposure supports complexity. The product is not capital protected and involves counterparty risk through collateralised structures. Securities lending or other features are not indicated as complexity drivers here. Hence, the classification is complex."
}